ARIPIPRAZOLE oral
Clinical Indication
Schizophrenia. Treatment and recurrence of mania. Control of agitation and disturbed behaviour in schizophrenia
Date of classification
September 2022
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .